0      0

Potency Strategy for a Fixed-Dose Combination Product

‐ Apr 22, 2021 11:20am

A bioassay case study summarizing the challenges in setting the control system of a combination product of two highly similar monoclonal therapeutic antibodies targeting the same cellular antigen: from similar modes of action and synergistic effect to the control of each molecule bioactivity in vitro.

Session Speaker(s):

You must be logged in and own this session in order to post comments.